Risk factor
Good trading liquidity
Profitability factor
Overvalued vs peers
About
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science,...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA, tr
Target Price
The average target price of 300347.SZ is 63 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio
Buy
Sell